Avalon GloboCare closes $3.25M private placement with up to $6.5M additional warrant proceeds

Avalon GloboCare Corp.

Issued 6,372,550 shares (or pre-funded warrants) at $0.51, plus Series A-1/A-2 warrants for 6,372,550 shares each at $0.51.
Gross proceeds $3.25M; net proceeds ~$2.8M after fees; warrants could add ~$6.5M if fully exercised.
Warrants exercisable only after stockholder approval; Series A-1 expire in 5 years, A-2 in 18 months from approval.
Net proceeds to be used for debt repayment and working capital.
Placement agent H.C. Wainwright; Roth Capital served as financial advisor.

item 1.01 item 3.02 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-022022
form_type: 8-K
ticker: ALBT
cik: 0001630212
company_name: Avalon GloboCare Corp.
filed_at: 2026-03-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.687447+00:00
generated_at: 2026-05-15T22:40:07.281849+00:00
sec_items: ["1.01", "3.02", "8.01", "9.01"]
event_type: debt
sentiment: neutral
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-022022
json_url: https://secwatch.observer/filing/0001213900-26-022022.json
markdown_url: https://secwatch.observer/filing/0001213900-26-022022.md
text_url: https://secwatch.observer/filing/0001213900-26-022022.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/0001213900-26-022022-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1630212/000121390026022022/ea0279124-8k_avalon.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001213900-26-022022

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.